Investigational Drug Information for Denufosol
✉ Email this page to a colleague
What is the drug development status for Denufosol?
Denufosol is an investigational drug.
There have been 15 clinical trials for Denufosol.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Fibrosis, Cystic Fibrosis, and Lung Diseases. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Cystic Fibrosis Foundation, and Cystic Fibrosis Foundation Therapeutics.
Summary for Denufosol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 141 |
| WIPO Patent Applications | 115 |
| Japanese Patent Applications | 64 |
| Clinical Trial Progress | Phase 3 (2008-02-01) |
| Vendors | 7 |
Recent Clinical Trials for Denufosol
| Title | Sponsor | Phase |
|---|---|---|
| A Safety and Tolerability Study of Denufosol in 2-4 Year Olds | Merck Sharp & Dohme Corp. | Phase 2 |
| Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642) | Merck Sharp & Dohme Corp. | Phase 3 |
| Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease | Merck Sharp & Dohme Corp. | Phase 3 |
Clinical Trial Summary for Denufosol
Top disease conditions for Denufosol
Top clinical trial sponsors for Denufosol
US Patents for Denufosol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
